Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-01

Study Completion Date

2017-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA). Poor adherence of this treatment decreases the control of the disease and the effectiveness of the associated treatments.

The aim would be to study the observance of patients with RA and to be able to propose adequate solutions favoring patient compliance and thus the stability of the pathology.

For this purpose, 3 methods of communication have been put in place to encourage adherence: usual care by the rheumatologist, sms sending or pharmaceutical maintenance.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

RhEumatoid Arthritis MEDIcation Adherence

NCT05413759

Rheumatoid Arthritis

RECRUITING NA

Impact of Behavioral Factors on Treatment Adherence in a Sample of Rheumatoid Arthritis Patients

NCT03754855

Arthritis, Rheumatoid

COMPLETED

Medication Adherence in Rheumatic Diseases

NCT06018350

Chronic Rheumatic Diseases

COMPLETED NA

Multidisciplinary Team Care in Rheumatoid Arthritis

NCT03099668

Rheumatoid Arthritis Multidisciplinary Communication

COMPLETED NA

Use of Remote Monitoring by Smartphone in the Care Management of Patients With Rheumatoid Arthritis

NCT03005925

Rheumatoid Arthritis

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Methotrexate Polyarthritis; Rheumatoid

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Group Type OTHER

Communication methods to encourage adherence

Intervention Type OTHER

Prospective randomized controlled study in intention to treat in open monocentric in 3 arms: all patients benefiting from the current management (medical consultation every 4 to 6 months in the department of rheumatology)

Send sms to patients

Group Type OTHER

Communication methods to encourage adherence

Intervention Type OTHER

Prospective randomized controlled study in intention to treat in open monocentric in 3 arms: all patients benefiting from the current management (medical consultation every 4 to 6 months in the department of rheumatology)

pharmaceutical maintenance following medical consultation

Group Type OTHER

Communication methods to encourage adherence

Intervention Type OTHER

Prospective randomized controlled study in intention to treat in open monocentric in 3 arms: all patients benefiting from the current management (medical consultation every 4 to 6 months in the department of rheumatology)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Communication methods to encourage adherence

Prospective randomized controlled study in intention to treat in open monocentric in 3 arms: all patients benefiting from the current management (medical consultation every 4 to 6 months in the department of rheumatology)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients attending Day Hospital or consultation of rheumatology with rheumatoid polyarteritis and under treatment with MTX alone or in combination with another therapeutic, fixed dosage for at least 3 months.
* Consenting Patient
* Literate French-speaking patient,
* Patient with a mobile phone
* Patient affiliated to a social security scheme